Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. [electronic resource]
Producer: 20160106Description: 3600-11 p. digitalISSN:- 1097-0142
- Carcinoma, Squamous Cell -- genetics
- Cyclin-Dependent Kinase Inhibitor p16
- ErbB Receptors -- metabolism
- Genetic Markers -- genetics
- Head and Neck Neoplasms -- genetics
- Humans
- Neoplasm Proteins -- genetics
- Neuregulin-1 -- genetics
- Prognosis
- Receptor, ErbB-2 -- metabolism
- Receptor, ErbB-3 -- genetics
- Retrospective Studies
- Squamous Cell Carcinoma of Head and Neck
- Survival Analysis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.